Soleus Capital Management, L.P. Kodiak Sciences Inc. Transaction History
Soleus Capital Management, L.P.
- $1.64 Billion
- Q3 2025
A detailed history of Soleus Capital Management, L.P. transactions in Kodiak Sciences Inc. stock. As of the latest transaction made, Soleus Capital Management, L.P. holds 19,644 shares of KOD stock, worth $383,254. This represents 0.02% of its overall portfolio holdings.
Number of Shares
19,644Holding current value
$383,254% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding KOD
# of Institutions
129Shares Held
44.4MCall Options Held
214KPut Options Held
224K-
Baker Bros. Advisors LP New York, NY17.3MShares$338 Million2.31% of portfolio
-
Black Rock Inc. New York, NY3.85MShares$75.1 Million0.0% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct2.84MShares$55.4 Million0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.95MShares$38.1 Million0.0% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA1.34MShares$26 Million0.04% of portfolio
About Kodiak Sciences Inc.
- Ticker KOD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,040,200
- Market Cap $1.02B
- Description
- Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...